Michal Říháček

机构：Masaryk University · ORCID：0000-0001-6533-6822

发表论文 21 篇 · 总被引 76 次 · h-index 4

代表论文

• B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia (2015 · BioMed Research International · 被引 24)
• Single-molecule microfluidic assay for prostate-specific antigen based on magnetic beads and upconversion nanoparticles (2024 · Lab on a Chip · 被引 13)
• Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma—a review and prospects for the future (2023 · Frontiers in Cardiovascular Medicine · 被引 12)
• New Findings in Methotrexate Pharmacology – Diagnostic Possibilities and Impact on Clinical Care (2015 · Klinicka onkologie · 被引 8)
• Sunitinib-Induced Elevation of Mean Corpuscular Volume (MCV)—Exploring Its Possible Clinical Relevance in Cancer Patients (2022 · Current Oncology · 被引 4)
• Utility of global longitudinal strain in early identification of chronic cardiotoxicity in asymptomatic long-term malignant lymphoma survivors with normal left ventricle ejection fraction (2025 · Scientific Reports · 被引 3)